Update on Study 19 trial of olaparib in serous ovarian cancer
Jonathan Ledermann, MD, FRCP from University College London, London, UK discusses his presentation on the update on the results of the Study 19 trial (NCT00753545). Study 19 was a randomized maintenan...
Author: VJOncology
Added: 08/17/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts